These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26433553)

  • 21. Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology.
    Sheikine Y; Kuo FC; Lindeman NI
    J Clin Oncol; 2017 Mar; 35(9):929-933. PubMed ID: 28297627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolving potential of companion diagnostics.
    Khoury JD
    Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating Genomics Into Clinical Pediatric Oncology Using the Molecular Tumor Board at the Memorial Sloan Kettering Cancer Center.
    Ortiz MV; Kobos R; Walsh M; Slotkin EK; Roberts S; Berger MF; Hameed M; Solit D; Ladanyi M; Shukla N; Kentsis A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1368-74. PubMed ID: 27082517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lung Cancer].
    Yoshida K; Kono T
    Gan To Kagaku Ryoho; 2016 Nov; 43(11):1321-1325. PubMed ID: 27899772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics and the History of Precision Oncology.
    Doroshow DB; Doroshow JH
    Surg Oncol Clin N Am; 2020 Jan; 29(1):35-49. PubMed ID: 31757312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Precision Oncology and "Molecular Tumor Boards" - Concepts, Chances and Challenges].
    Holch JW; Westphalen CB; Hiddemann W; Heinemann V; Jung A; Metzeler KH
    Dtsch Med Wochenschr; 2017 Nov; 142(22):1676-1684. PubMed ID: 29078213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Master protocols in lung cancer: experience from Lung Master Protocol.
    Lam VK; Papadimitrakopoulou V
    Curr Opin Oncol; 2018 Mar; 30(2):92-97. PubMed ID: 29329112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Trials of Precision Medicine through Molecular Profiling: Focus on Breast Cancer.
    Zardavas D; Piccart-Gebhart M
    Am Soc Clin Oncol Educ Book; 2015; ():e183-90. PubMed ID: 25993171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Master Observational Trial: A New Class of Master Protocol to Advance Precision Medicine.
    Dickson D; Johnson J; Bergan R; Owens R; Subbiah V; Kurzrock R
    Cell; 2020 Jan; 180(1):9-14. PubMed ID: 31951522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Definitions and statistical properties of master protocols for personalized medicine in oncology.
    Renfro LA; Mandrekar SJ
    J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of precision oncology trials: challenges and opportunities.
    Fountzilas E; Tsimberidou AM
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):797-804. PubMed ID: 30044653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of tumor sequencing on the use of anticancer drugs.
    Thomas F; Desmedt C; Aftimos P; Awada A
    Curr Opin Oncol; 2014 May; 26(3):347-56. PubMed ID: 24709974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical utility of next-generation sequencing in precision oncology.
    Hux A; Lewis A; Sachwitz D; Gregory T
    JAAPA; 2019 Jan; 32(1):35-39. PubMed ID: 30589734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progress in precision therapy in pediatric oncology.
    O'Donohue T; Farouk Sait S; Glade Bender J
    Curr Opin Pediatr; 2023 Feb; 35(1):41-47. PubMed ID: 36377257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precision oncology: A new era of cancer clinical trials.
    Renfro LA; An MW; Mandrekar SJ
    Cancer Lett; 2017 Feb; 387():121-126. PubMed ID: 26987624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NCI-MATCH launch highlights new trial design in precision-medicine era.
    McNeil C
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142446
    [No Abstract]   [Full Text] [Related]  

  • 39. The Personalization of Therapy: Molecular Profiling Technologies and Their Application.
    Zeron-Medina J; Ochoa de Olza M; Braña I; Rodon J
    Semin Oncol; 2015 Dec; 42(6):775-87. PubMed ID: 26615125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of high-throughput sequencing in oncology].
    Rodrigues MJ; Gomez-Roca C
    Bull Cancer; 2013 Mar; 100(3):295-301. PubMed ID: 23501647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.